DUSLX | VIGIX | DUSLX / VIGIX | |
Total Expense Ratio | 0.18 | 0.04 | 450% |
Annual Report Gross Expense Ratio | 0.18 | 0.04 | 450% |
Fund Existence | 13 years | 27 years | - |
Gain YTD | 8.318 | 7.726 | 108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.8B | 294B | 1% |
Annual Yield % from dividends | 0.96 | 0.45 | 211% |
Returns for 1 year | 14.13 | 15.43 | 92% |
Returns for 3 years | 64.44 | 96.42 | 67% |
Returns for 5 years | 83.37 | 115.38 | 72% |
Returns for 10 years | 193.98 | 312.91 | 62% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RDLAX | 11.28 | 0.11 | +0.98% |
Columbia Disciplined Growth A | |||
GFVUX | 16.02 | 0.15 | +0.95% |
Goldman Sachs Focused Value R6 | |||
MALOX | 20.82 | 0.07 | +0.34% |
BlackRock Global Allocation Instl | |||
AIVBX | 19.46 | -0.01 | -0.05% |
American Funds International Vntg A | |||
ERHSX | 14.05 | -0.03 | -0.21% |
Eaton Vance Worldwide Health Sci R |